Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use

Am J Geriatr Psychiatry. 2011 Feb;19(2):169-75. doi: 10.1097/JGP.0b013e3181e4490d.

Abstract

Objectives: This study examined whether some of the age-associated decrements in basic cognitive resources (information-processing speed and working memory) result from anticholinergic medication use (as measured by serum anticholinergic activity [SAA]) and whether such decrements are lessened by caffeine.

Design: Cross-sectional observational study.

Setting: University medical center.

Participants: One hundred fifty-two normal-elderly community volunteers.

Measurements: Two tests each of information-processing speed and of working memory were administered, and blood samples were drawn before and after cognitive testing to determine serum levels of anticholinergic activity and of paraxanthine-a caffeine metabolite.

Results: Elevated SAA was associated with a significant but modest slowing in information-processing time but only in those individuals who had low levels of serum paraxanthine. SAA did not correlate with performance on tests of working memory.

Conclusions: These results suggest that anticholinergic medications are a relatively minor contributor to the decrements in basic processing resources commonly found in studies of normal aging.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Caffeine / pharmacology*
  • Cholinergic Antagonists / blood*
  • Cholinergic Antagonists / pharmacology
  • Cognition / drug effects*
  • Cognition Disorders / blood
  • Cognition Disorders / prevention & control
  • Drug Antagonism
  • Female
  • Humans
  • Male
  • Memory, Short-Term / drug effects
  • Neuropsychological Tests
  • Reaction Time / drug effects

Substances

  • Cholinergic Antagonists
  • Caffeine